Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Nature Medicine|June 1, 1997
ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agentsC Heise, A Sampson-Johannes, A Williams, et al.Nature Medicine|October 4, 2000
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacyC Heise, T Hermiston, L Johnson, et al.Journal of Orthopaedic Trauma|January 1, 1997
Intraoperative monitoring of motor pathways during operative fixation of acute acetabular fracturesD L Helfet, N Anand, A L Malkani, et al.Anti-Cancer Drugs|March 27, 2002
Efficient induction of apoptosis by ONYX-015 adenovirus in human colon cancer cell lines regardless of p53 statusT Petit, K K Davidson, C Cerna, et al.Cancer Research|March 23, 2000
In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapyK R Rogulski, S O Freytag, K Zhang, et al.Oncogene|October 27, 1998
PTEN/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostateJ T Dong, T W Sipe, E R Hyytinen, et al.Science (New York, N.Y.)|October 18, 1996
An adenovirus mutant that replicates selectively in p53-deficient human tumor cellsJ R Bischoff, D H Kirn, A Williams, et al.British Journal of Haematology|August 14, 2012
Single-agent lenalidomide in relapsed/refractory mantle cell lymphoma: results from a UK phase II study suggest activity and possible gender differencesHeather E Eve, Sean Carey, Sarah J Richardson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancerI Ganly, D Kirn, G Eckhardt, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
CHIR-258 is efficacious in a newly developed fibroblast growth factor receptor 3-expressing orthotopic multiple myeloma model in miceXiaohua Xin, Tinya J Abrams, Paul W Hollenbach, et al.Pageof 4